Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients.
Conclusion: There is a significant increase risk of thrombosis in ET patients with CALR mutation, thrombophilic mutations, as well as factor V Leiden and prothrombin gene mutation with a risk of developing leukemic transformation.
PMID: 32292481 [PubMed]
Source: Advances in Hematology - Category: Hematology Tags: Adv Hematol Source Type: research
More News: Cardiology | Cardiovascular | Egypt Health | Genetics | Heart | Hematology | Leukemia | Myeloproliferative Disorders | Statistics | Study | Thrombosis